Dr. Atousa Ordobazari, MD

  • Tampa, FL
  • Pathologist
NPI1093014250PAC ID5991121238
Medicare services, 2024
1,333
Medicare patients, 2024
335
Publications
4
MIPS score, 2024
88
Hospital affiliations
1
Practice address
10901 McKinley Dr, Tampa, FL 33612
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

H Lee Moffitt Cancer Center & Research Institute I - HOPD

Acute Care Hospital outpatient department · Tampa, Florida

See all 8 affiliations

Find Dr. Ordobazari's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Atousa Ordobazari is a pathologist in Tampa, Florida

Dr. Ordobazari practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Ordobazari's NPI, 1093014250, was assigned on March 26, 2011. Dr. Ordobazari graduated from Shahid Beheshti University of Medical Sciences in 2005. Dr. Ordobazari holds Florida license ME140450.

NPI and contact details
Medicare PAC ID
5991121238
NPI enumeration date
March 26, 2011
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Atousa Ordobazari practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida

Dr. Ordobazari's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

  • H Lee Moffitt Cancer Center & Research Institute I - HOPD
    10901 McKinley Dr, Tampa, FL 33612

Source: Dmand AI Affiliation Data

Dr. Atousa Ordobazari is affiliated with 5 sites of care and 3 medical groups

Dr. Ordobazari's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Ordobazari is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Ordobazari to 3 more group practices and clinics and 2 medical groups, each named with a free account.

See all 8 affiliations for Dr. Ordobazari

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Atousa Ordobazari's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ordobazari practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
H Lee Moffitt Cancer Center & Research Institute I - HOPDAvailable with a free account
+4 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Ordobazari practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Atousa Ordobazari is one of 832 pathologists in Florida

Anatomic pathology and clinical pathology is Dr. Ordobazari's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Ordobazari is board certified in cytopathology by the American Board of Pathology. Dmand AI has Dr. Ordobazari's licenses on file in 14 states: Florida, New York, Oregon, Utah, Arizona, Indiana, Maryland, New Jersey, Pennsylvania, Wisconsin, West Virginia, District of Columbia, Idaho and Tennessee.

Specialties and state licenses

  • Anatomic pathology and clinical pathology, FloridaPrimaryLicense ME140450 · 2019 to 2027 · taxonomy 207ZP0102X
  • New York license2017 to 2024
  • Oregon license2019 to 2023
  • Utah license2018 to 2022
  • Arizona license2018 to 2021
  • Indiana license2018 to 2021
  • Maryland license2019 to 2021
  • New Jersey license2019 to 2021
  • Pennsylvania license2018 to 2021
  • Wisconsin license2013 to 2021
  • West Virginia license2018 to 2021
  • District of Columbia license2018 to 2020
  • Idaho license2018 to 2020
  • Tennessee license2018 to 2020

Pathologists near Dr. Ordobazari

Counts of pathologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Atousa Ordobazari billed Medicare for 1,333 services in 2024

CMS data shows 1,333 Medicare services from Dr. Ordobazari across 12 procedure codes in 2024, for 335 Medicare patients. Medicare paid $38,912 for them.

Medicare services, 20241,333
Medicare patients335
Paid by Medicare$38,912
Procedure codes12

Dr. Ordobazari's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 1,5062024: 1,31313%
Imaging
2023: 172024: 2018%

Where Dr. Ordobazari's Medicare services took place, 2024

  • In an office202%
  • In a facility1,31398%

Dr. Ordobazari compared with the Florida median for pathologists, 2024

  • Dr. Ordobazari
  • Florida median
Medicare services
1,333vs 1,4256% below
Medicare patients
335vs 54739% below

Medians across 732 pathologists in Florida with Dmand AI profiles that report each measure.

Dr. Ordobazari's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Ordobazari

Need commercial claims for Dr. Ordobazari?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ordobazari and other pathologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Atousa Ordobazari treated 335 Medicare patients in 2024, average age 73

CMS counts 335 Medicare patients who saw Dr. Ordobazari in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ordobazari's median patient age at 64, with 83% women.

Medicare patients, 2024335
Average age73
Average risk score2.00
Also on Medicaid5%

Dr. Ordobazari's Medicare patients by age, 2024

Dr. Ordobazari's Medicare patients by sex, 2024

  • Women24673%
  • Men8927%

Chronic conditions among Dr. Ordobazari's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure73%
  3. Cancer59%
  4. Arthritis49%
  5. Chronic kidney disease32%
  6. Anxiety31%
  7. Mood disorders28%
  8. Ischemic heart disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Ordobazari's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women83%
  • Men16%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Atousa Ordobazari scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ordobazari for performance year 2024, reported as part of a group. Dr. Ordobazari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Ordobazari's MIPS scores, performance year 2024

  • 88of 100Final score
  • 74of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find pathologists like Dr. Ordobazari by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Atousa Ordobazari has 4 publications on record

Dmand AI links 4 papers to Dr. Ordobazari, published from 2016 to 2024. Dr. Ordobazari's most frequent co-authors are Sadhvi Batra, MD, Monica T. Garcia-Buitrago and Carmen Gomez-Fernandez.

Papers4
Years published2016 to 2024

Dr. Ordobazari's papers by year, 2016 to 2024

Dr. Ordobazari's most frequent co-authors

Recent publications by Dr. Ordobazari

See all 4 publications and co-authors

See who Dr. Ordobazari researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ordobazari works with, so you can find a warm path to the right pathologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Atousa Ordobazari received $18 in industry payments in 2021

CMS Open Payments shows 1 general payment to Dr. Ordobazari from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $18.

Companies that paid Dr. Ordobazari the most, 2021 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Ordobazari

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Atousa Ordobazari graduated from Shahid Beheshti University of Medical Sciences

Dr. Ordobazari graduated from Shahid Beheshti University of Medical Sciences in 2005.

  1. Medical schoolShahid Beheshti University of Medical Sciences
  2. Board certified in cytopathologyAmerican Board of Pathology
  3. Board certified in pathology - anatomic/pathology - clinicalAmerican Board of Pathology

Source: Dmand AI Professional Profile Data

Dr. Atousa Ordobazari accepts plans from 4 insurance carriers

Dr. Ordobazari is in network with 4 carriers, including Elevance, Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.

  • Elevance
  • Excellus BlueCross BlueShield
  • CMS Medicare
  • WI State Medicaid

Plan types Dr. Ordobazari accepts, by number of carriers

  1. Medicare3
  2. EPO2
  3. HMO2
  4. POS2
  5. PPO2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Atousa Ordobazari's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Atousa Ordobazari

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Atousa Ordobazari's NPI number?

Dr. Atousa Ordobazari's NPI number is 1093014250. It was assigned on March 26, 2011, and it is active in the NPI Registry.

What kind of doctor is Dr. Atousa Ordobazari?

Dr. Atousa Ordobazari is a pathologist in Tampa, Florida. The primary specialty in the NPI Registry is Anatomic Pathology & Clinical Pathology Physician (taxonomy code 207ZP0102X).

Where does Dr. Atousa Ordobazari practice?

Dr. Ordobazari practices at 10901 McKinley Dr, Tampa, FL 33612. Dr. Ordobazari's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dmand AI also links Dr. Ordobazari to 3 group practices and clinics and 2 medical groups.

What is Dr. Atousa Ordobazari's medical license number?

Dr. Ordobazari holds Florida license ME140450, one of the licenses on file in 14 states.

Which states has Dr. Atousa Ordobazari been licensed in?

Dmand AI has state licenses on file for Dr. Ordobazari in Florida (2019 to 2027), New York (2017 to 2024), Oregon (2019 to 2023), Utah (2018 to 2022), Arizona (2018 to 2021), Indiana (2018 to 2021), Maryland (2019 to 2021), New Jersey (2019 to 2021), Pennsylvania (2018 to 2021), Wisconsin (2013 to 2021), West Virginia (2018 to 2021), District of Columbia (2018 to 2020), Idaho (2018 to 2020) and Tennessee (2018 to 2020).

Which hospitals is Dr. Atousa Ordobazari affiliated with?

Dr. Ordobazari is affiliated with Moffitt Cancer Hospital.

What medical group is Dr. Atousa Ordobazari part of?

Dr. Ordobazari is linked to Moffitt Cancer Center. Dmand AI links Dr. Ordobazari to 2 more medical groups.

Does Dr. Atousa Ordobazari accept Medicare?

Yes. CMS data shows Dr. Ordobazari billed Medicare for 1,333 services in 2024, and Dr. Ordobazari accepts Medicare assignment.

What is Dr. Atousa Ordobazari's MIPS score?

Dr. Ordobazari's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

How many Medicare patients does Dr. Atousa Ordobazari see?

CMS counts 335 Medicare patients who saw Dr. Ordobazari in 2024, with an average age of 73.

Show 8 more questionsShow fewer questions

Is Dr. Atousa Ordobazari board certified?

Yes. Dr. Ordobazari is board certified in cytopathology by the American Board of Pathology.

What services does Dr. Atousa Ordobazari bill to Medicare?

In 2024, Dr. Ordobazari's most billed Medicare services were lab and pathology test (88341), lab and pathology test (88305) and lab and pathology test (88342).

Where did Dr. Atousa Ordobazari go to medical school?

Dr. Ordobazari graduated from Shahid Beheshti University of Medical Sciences in 2005.

Has Dr. Atousa Ordobazari received payments from drug or device companies?

CMS Open Payments shows $18 in general payments to Dr. Ordobazari from 1 company from 2021 to 2021. The largest total came from Roche Diagnostics Corporation.

How long has Dr. Atousa Ordobazari been practicing?

Dr. Ordobazari graduated from medical school in 2005, 21 years ago.

Does Dr. Atousa Ordobazari do research?

Dmand AI links 4 publications to Dr. Ordobazari, published from 2016 to 2024.

Who does Dr. Atousa Ordobazari publish with?

Dr. Ordobazari's most frequent co-authors are Sadhvi Batra, MD (1 shared paper), Monica T. Garcia-Buitrago (1 shared paper) and Carmen Gomez-Fernandez (1 shared paper).

What insurance does Dr. Atousa Ordobazari accept?

Dr. Ordobazari is in network with 4 carriers, including Elevance, Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.

Selling to anatomic pathology and clinical pathology practices?

See pathologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)